Silence Therapeutics, Plc. revenue breakdown overview

Silence Therapeutics, Plc. revenue for the last year amounted to 32.30 M USD, the most of which — 17.42 M USD — came from its highest performing source at the moment, Research Collaboration - AstraZeneca, the year earlier bringing 6.14 M USD. The greatest contribution to the revenue figure was made by United Kingdom — last year it brought Silence Therapeutics, Plc. 31.58 M USD, and the year before that — 20.47 M USD.